Swiss pharmaceutical giant Roche said Tuesday that it had received clearance from health safety regulators to sell a new blood test for early detection of Alzheimer’s disease in the European Union.
Continue Reading this article here
Roche cleared to launch early Alzheimer’s test in EU: company
